A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01

Stopped Insufficient efficacy for this indication. The study stopped after Part B.

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG: GLWL-01, Part A
• DRUG: Placebo, Part A
• DRUG: GLWL-01, Part B
• DRUG: Placebo, Part B
• DRUG: GLWL-01, Part C
• DRUG: Placebo, Part C

Sponsor

GLWL Research Inc.